BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7185533)

  • 1. Comparison of theophylline bioavailability from single doses of an elixir and two multi-ingredient tablets.
    Dumas WB; Murphy JE; Shleifer NH; Shah VR
    Clin Pharm; 1982; 1(4):368-70. PubMed ID: 7185533
    [No Abstract]   [Full Text] [Related]  

  • 2. Absolute bioavailability of oral theophylline.
    Hendeles L; Weinberger M; Bighley L
    Am J Hosp Pharm; 1977 May; 34(5):525-7. PubMed ID: 868891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI; French IW; Mildon CA
    Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and multiple dose characteristics of a new sustained release theophylline tablet.
    Spangler DL; Vanderpool GE; Carroll MS; Tinkelman DG
    Ann Allergy; 1980 Dec; 45(6):355-9. PubMed ID: 7447084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability and release pattern of whole and halved sustained-release theophylline tablets.
    Leeds NH; Gal P; Purohit AA; Walter JB
    Clin Pharm; 1982; 1(2):163-4. PubMed ID: 7185516
    [No Abstract]   [Full Text] [Related]  

  • 10. Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.
    Shen DD; Fixley M; Azarnoff DL
    J Pharm Sci; 1978 Jul; 67(7):916-9. PubMed ID: 660507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of microcrystalline theophylline (Nuelin) and theophyllamine tablets].
    Bakke OM; Apold J
    Tidsskr Nor Laegeforen; 1979 Feb; 99(6):319-21. PubMed ID: 371068
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacodynamics of oxtriphylline PEC tablets vs. elixir in the treatment of asthma.
    Falliers CJ; Redding MA; Katsampes CP
    Ann Allergy; 1980 Nov; 45(5):271-5. PubMed ID: 7436053
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation on bioavailability of theophylline.
    Welling PG; Domoradzki J; Sims JA; Reed CE
    J Clin Pharmacol; 1976 Jan; 16(1):43-50. PubMed ID: 1245607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative absorption of theophylline from theophylline-guaifenesin tablets and liquid and from a reference theophylline liquid.
    Harrison LI; Chang SF; Welscher TM; Ober RE
    Clin Ther; 1981; 4(1):18-23. PubMed ID: 7273065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo testing of a peroral theophylline depot preparation with zero-order release].
    Lippold BC; Förster H
    Arzneimittelforschung; 1984; 34(7):824-9. PubMed ID: 6541919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapidly dissolving theophylline tablet.
    Cohen A; Johnson C; Re O
    Curr Ther Res Clin Exp; 1975 May; 17(5):497-505. PubMed ID: 805034
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.